Genome mining for macrolactam-encoding gene clusters allowed for the network-guided isolation of β-amino acid-containing cyclic derivatives and heterologous production of ciromicin A

β-Amino acid-containing macrolactams represent a structurally diverse group of bioactive natural products derived from polyketides; however we are currently lacking a comprehensive overview about their abundance across bacterial families and the underlying biosynthetic diversity. In this study, we employed a targeted β-amino acid-specific homology-based multi-query search to identify potential bacterial macrolactam producers. Here we demonstrate that approximately 10% of each of the identified actinobacterial genera harbor a biosynthetic gene cluster (BGC) encoding macrolactam production. Based on our comparative study, we propose that mutations occurring in specific regions of polyketide synthases (PKS) are the primary drivers behind the variation in macrolactam ring sizes. We successfully validated two producers of ciromicin A from the genus Amycolatopsis, revised the composition of the biosynthetic gene cluster region mte of macrotermycins, and confirmed the ciromicin biosynthetic pathway through heterologous expression. Additionally, network-based metabolomic analysis uncovered three previously unreported macrotermycin congeners from Amycolatopsis sp. M39. The combination of targeted mining and network-based analysis serves as a powerful tool for identifying macrolactam producers and our studies will catalyze the future discovery of yet unreported macrolactams.


P
olyketide-derived macrolactams are a diverse and complex family of natural products with exceptional pharmacological properties, including antibiotic, antifungal, anticancer, and immunosuppressant activities 1 .Macrolactams have been predominately isolated from Actinobacteria of various ecological habitats and are characterized by the presence of an alkyl/alkenyl or aryl-substituted β-amino acid starter unit (Fig. 1) and a polyenylcarboxylic acid (polyketide), connected by an amide bond to form a macrolactam ring of varying size (Figs.S1, S2) 2,3 .In addition, spontaneous intramolecular cyclization reactions and post-assembly modifications via accessory enzymes largely contribute to the structural diversity of macrolactams 2,4 .In general, macrolactams can be grouped according to the different types of starter units into five structural categories.Macrolactams that contain the L-glutamate-derived 3-amino-2-methylpropionate (3-Amp) motif include well-studied compounds such as the 20membered vicenistatin 5 , the 22-membered ciromicins Α-B 6 , as well as 26-membered macrolactams such as sceliphrolactam 7 and bombyxamycins Α-B 8 .On the other hand, derivatives carrying a 3-aminobutyrate (3-Aba)-motif include the 24-membered incednine 9 , and the 26-membered lobosamides 10 , among many other examples (Figs.S1, S2) 2 .Derivatives containing a βphenylalanine (β-Phe) as an characteristic feature include hitachimycin (stubomycin) 11 and viridenomycin 12 , while fluvirucins 13,14 possess a β-alanine (β-Ala) moiety.Furthermore, macrolactams carrying 3-amino fatty acids (3-Afa) [15][16][17][18][19] have been identified, such as the 20-membered heronamides 20,21 , the 22-membered cremimycin 22 , and the largest yet known polyene macrolactam, 34-membered sagamilactam 23 .Based on an ecology-driven approach, we previously reported the isolation of the 20-membered 3-Amp-containing macrolactams termed macrotermycin A-D from a defensive bacterial symbiont, the actinobacterium Amycolatopsis sp.M39 24 .Short-read genome sequencing of the producer allowed us to identify a macrolactamencoding gene cluster region (mte) and propose a first, but incomplete biosynthetic pathway (mte).In frame of these studies, we realized that despite intensive research efforts, the genetic diversity and regulation of macrolactam encoding gene clusters, and with that the general abundance of macrolactam producers in the bacterial world, has only sparsely been described.Thus, we followed up on our and other groups prior work and evaluated the diversity and organization of macrolactam-encoding biosynthetic gene clusters (BGC) across the bacterial kingdom.Findings of this study uncovered that macrolactam-encoding BGCs are more widespread than originally anticipated and enabled us to revise the structure and composition of the mte pathway in Amycolatopsis sp.M39.To complement our in silico studies, we employed a comparative metabolomics approach, which enabled the isolation of yet unreported macrotermycin derivatives, as well as the predicted macrolactam ciromicin A from two actinobacterial producers.Additionally, we proved the ciromicin biosynthetic pathway by heterologous production.
We then assessed the distribution and relative abundance of different macrolactam biosynthetic gene cluster types across the bacterial kingdom (Supplementary Data file 2, Table S1) 26 , with the assumption that the macrolactam biosynthesis can be broadly categorized into four different phases (Fig. 2).Typically, the first phase involves the biosynthesis of the essential β-amino acid (the starter unit) through a series of enzyme-mediated transformations 27 .In the second phase, the β-amino acid is activated by being loaded onto a discrete acyl carrier protein (ACP) domain by a β-amino acid specific adenylation (A) domain.Afterwards the N-terminus is protected and undergoes further modifications before being loaded onto the starter ACP of a modular type I polyketide synthase (PKS) by a stand-alone acyltransferase (AT) domain 3 .The third phase involves elongation of the polyketide chain using extender units defined by each single module of the PKS.The chain is then cyclized by a thioesterase (TE) domain located within the final PKS module to form the macrocyclic lactam core structure.In the fourth and final phase, the core macrolactam undergoes further modifications by tailoring enzymes, such as glycosyltransferases (GT), methyltransferases (MT), and cytochrome P450 (Ox) enzymes.Due to their polyenic nature, macrolactams have been observed, although not exclusively, to undergo intramolecular cyclization reactions upon abiotic and spontaneous stimuli, leading to further structural diversification of the compound class 4 .
Based on these biosynthetic considerations, we selected several conserved biosynthetic enzymes, which are involved in the different phases of precursor and macrolactam biosynthesis (Fig. 3a), for homology searches against the NCBI database using cblaster v1.3.11(Supplementary Data file 2).As query sequences, we included enzymes involved in amino acid incorporation that are universally present and unique for all macrolactam BGCs, enzymes involved in β-amino acid biosynthesis to distinguish between different BGC types, and one PKS (IdnP1) to account for a type I PKS assembly line encoded in proximity to the starter unit biosynthesis.Due to the highly varying length and module composition of the PKS enzymes in macrolactam BGCs, accurate prediction of PKS homologs was challenging, and hits with ambiguous cluster architecture were curated manually.
Using this query input, we identified 435 genomes, all of which belonged to Actinobacteria and encoded a macrolactam-related biosynthetic gene cluster.The majority of the BGCs (295/68%) was detected in the Streptomycetaceae, followed by Pseudonocardiaceae (52/12%), Micromonosporaceae (41/9%), Streptosporangiaceae (23/5%), Thermomonosporaceae (13/3%), and others (11/3%) (Fig. 3b).We also uncovered that 3-Amp and 3-Aba-type BGCs were more broadly distributed, whereas 3-Afa, β-Phe and β-Ala clusters were found only in a few strains (Fig. 3c); a finding that correlated to the abundance and origin of isolated macrolactam natural products (Figs.S4, S5).Here, we acknowledge that the relative overrepresentation of BGCs in certain families might also relate to the higher abundance of genomes of e.g., Streptomycetaceae in public databases (Fig. S6).Intriguingly, the distribution of the five macrolactam BGC types varied extensively across bacterial genera (Fig. S7).While all five types were identified in Streptomyces, only four were found in Micromonospora, three in Actinomadura, two in Actinoplanes  2 The four phases of macrolactam biosynthesis exemplified by vicenistatin biosynthesis.In the first phase, enzyme-mediated transformations lead to the formation of the β-amino acid starter unit.The second step is common for all macrolactam BGCs and includes activation, protection and loading of the starter unit onto the first PKS.In phase 3, the polyketide chain is elongated by a PKS assembly line following deprotection and macrolactamization.Post-assembly modifications are introduced via accessory enzymes and spontaneous intramolecular cyclization may occur (phase 4).The stereochemical assignment of the macrolactam core structure was excluded to enhance clarity.and one in Amycolatopsis.3-Amp-type BGCs were found in all genera, while 3-Aba was the dominant starter unit in Micromonospora, 3-Afa-types were almost exclusively found in Streptomyces and Actinomadura and β-Phe BGCs were only identified in Streptomyces and Micromonospora.
Revised organization of the mte BGC.Based on these findings, we then reanalyzed the originally described mte cluster sequence and found that the sequence encoded less PKS genes than required for a canonical biosynthetic assembly line of the 20membered macrotermycins, and additionally was lacking the genes related to xylosamine (aminosugar) biosynthesis (Fig. S8) 24 .
To address these inconsistencies, we resequenced the strain first with short-read sequencing, which resulted in two differently fragmented mte clusters, and then with long-read sequencing that afforded a complete cluster sequence (Fig. S9).
A genome-to-genome distance analysis 28 of the WGS uncovered that strain M39 is very closely related to Amycolatopsis rubida DSM44637 (dDDH (d 4 ): 93.2%) and could be regarded as an isolate of the same species.A. rubida DSM44637 encodes a nearly identical macrolactam BGC predicted to generate a 20membered macrolactam.Sequence alignment of all three obtained genome assemblies with the A. rubida genome allowed locating the missing biosynthetic genes in the previously published mte BGC (Fig. S9) yielding a complete mte BGC region with a predicted PKS domain architecture that matched the formation of the 20-membered macrotermycins (Figs.S9-S12, Table S2).Overall, six PKS genes with ten modules were annotated, of which modules M9 and M10 (MteP3) are proposed to be non-functional due to the lack of crucial domains (Figs. 4,  5).We then compared the organization of the mte BGC encoded in the genome of Amycolatopsis sp.M39 with the other identified  Amycolatopsis-derived BGCs (28) that encode the biosynthesis of the 3-Amp starter unit (Figs. 4, S8) to predict the structural space of Amp-containing macrolactams 29 .All 28 detected BGCs shared a similar architecture, containing genes responsible for 3-Amp biosynthesis (phase 1), incorporation (phase 2), polyketide elongation (phase 3) and modification (phase 4).Most clusters contained six PKS genes encoding for a total number of ten modules with only one exception for Amycolatopsis xylanica, which encoded a PKS assembly line with eleven PKS modules resembling the domain architecture of the bombyxamycin (bom) BGC 8 .Across the BGCs, the genes for PKS1/2 and PKS4-6 showed identical module composition, while modules of PKS3 lacked certain domains, which could be the cause of varying ring sizes of the macrolactam products.We also observed differences in the number of tailoring enzymes responsible for oxidation (CYPs) or glycosylation (GTs).While many BGCs contained only one CYP and one GT homolog, some clusters encoded for two GT homologs, and others encoded none (Fig. S8).Interestingly, the revised mte gene cluster region also contained three glycosyltransferase and two cytochrome P450 encoding genes similar to the macrolactam cluster of A. rubida.Alignment of the glycosyltransferase sequences (Fig. S11) revealed that MteG1 and  G2 (420/417 aa) share homologies with AurS5 (55% and 59% identity, respectively), harboring the necessary residues for acceptor and donor binding.In contrast, MteG3 (298 aa) showed similarities to the truncated AurS4 (47% identity), suggesting that MteG3 might act in combination with MteG1 or G2 as exemplified in auroramycin biosynthesis 30 .We also noted the presence of a γ-butyrolactone (γ-BL) biosynthesis subcluster downstream of each macrolactam BGC 31 , which may be responsible for the regulation of macrolactam biosynthesis in response to environmental stressors 32 .
Deduction of two putative ciromicin producers.The comparative study also revealed that our recently discovered birdassociated Amycolatopsis sp.PS_44_ISF1 (closest related type strain: A. saalfeldensis DSM 44993 33 ) carried a macrolactam biosynthetic gene cluster (pac), whose arrangement showed high similarities to the asa gene cluster of A. saalfeldensis DSM 44993 and the ciromicin (cir) 6 cluster from Amycolatopsis sp.FU40, and partial similarities to the mte cluster 24 from Amycolatopsis sp.M39 (Fig. 4, Tables S2, S4).
Thus, we pursued a detailed analysis of the predicted protein sequences of the pac and asa gene cluster to deduce the core structure of the yet unidentified encoded macrolactam.Both gene cluster regions (pac, asa) encode for 39-40 open reading frames (pacR1-Y2, asaR1-Y2 with identical gene arrangement), spanning at least 86.2-86.4kb (in asa BGC an additional gene of unknown function is present between asaD and E) (Fig. 6, Table S2).Both clusters contain six PKS genes (P1-6), three β-amino acid biosynthetic genes (F-H), four genes involved in amino acid incorporation (B-E), one cytochrome P450 monooxygenase gene (O1), three xylosamine biosynthetic genes (S1-3), two glycosyltransferase-encoding genes (G1-2), four transporter (T1-4), eight regulatory genes (R1-8), and several other accessory genes.A set of seven genes (pacB-H) is predicted to encode for the biosynthesis, activation, and loading of the 3-amino-2methylaspartate (3-Amp) precursor.In short, the glutamate mutase subunits PacG and PacH are likely responsible for the conversion of L-glutamate to 3-methylaspartate, which should be recognized by adenylation enzyme PacE and transferred onto the standalone ACP PacC.After decarboxylation by decarboxylase PacF to yield 3-Amp, another adenylation enzyme, PacD, transfers L-alanine as a protecting group onto the resulting terminal amino group to prevent internal cyclization during the following PKS assembly line 34 .Subsequently, the trans-acting acyltransferase PacB is proposed to transfer the protected precursor onto the first ACP of the type I modular polyketide synthase assembly line (PKS, pacP1-6).Similar to the cir cluster 6 , the last module 10 of PacP3 lacks a ketoreductase (KR) and harbors an incomplete catalytic triad within the dehydratase domain.This mutation in PacP3 differs from those within the mte cluster where both, modules 9 and 10, are proposed to be non-functional.As mutations and variations within the structure of PKS3 are widespread in Amycolatopsis macrolactam BGCs, corresponding variations of the macrolactam ring sizes are regularly observed.Lastly, the amidohydrolase PacA is supposed to remove the alanine protecting group, while the terminal thioesterase (TE) domain in PacP3 or the standalone TE PacI catalyzes the lactam formation resulting in intermediate I.
Assuming a canonical polyketide assembly line, we predicted a 22-membered macrolactam scaffold (intermediate I) as aglycon product of this BGC, similar to ciromicin A biosynthesis.
The annotated cytochrome P450 enzyme PacO1 showed high similarity to CirO1 (86% identity), which has been proposed to catalyze the oxidation of the methylated C-8 in ciromicin, hence producing the proposed intermediate II (phase 4) 7 .Glycosyltransferase PacG1 showed high similarity to the putative ciromicin homolog CirG2 (86.4% compared to 24.3% identity for PacG2) and AurS5 (59%) 30 while GT PacG2 was more related to its truncated partner AurS4 (42%).
Due to the high similarity of PacS1-PacS3 with xylosaminerelated biosynthetic enzymes within the auroramycin 30 and ciromicin 6 pathways, we deduced xylosamine to be the most likely product of PacS1-PacS3 and to serve as substrate for the encoded glycosyltransferases. Here, we propose that both glycosyltransferases, PacG1 and PacG2 are required for the glycosylation event of position C-9 (intermediate III) using xylosamine as reported for the auroramycin biosynthesis.Similar to the ciromicin biosynthesis 6 , a second oxidation step (most likely an epoxidation) of the C-18/C-19 double bond (intermediate IV), followed by a nucleophilic attack of the amino group at C-18, may lead to the formation of a pyrrolidinol ring likely leading to the ciromicin core structure.A similar mechanism was also proposed for other macrolactams, such as heronamides 35 , dracolactams 36 , and the depicted niizalactams 37 .
We also noted a diverse set of regulatory genes (pacR1-8) in both pathways, such as a homolog of the LuxR family transcriptional regulator aurR1 (pacR3, identity 42%), suggesting a similar regulation of macrolactam biosynthesis in A. saalfeldensis and Amycolatopsis sp.PS_44_ISF1.Furthermore, homologous genes corresponding to the γ-BL regulation system 32 are close to the BGC (pacR5-9, pacY1-2).A third level of regulation may be coordinated by the two-component system of the proposed sensor histidine kinase and its partner response regulator (pacR1/2), which also functions in sensing environmental conditions to regulate gene expression in bacteria 38 .
Isolation of predicted macrolactam scaffolds.In the next step, we evaluated if Amycolatopsis sp.PS_44_ISF1 (pac BGC) and A. saalfeldensis (asa BGC) exhibited similar antifungal activity and macrolactam production as Amycolatopsis sp.M39 (mte BGC) by using bacterial-fungal co-cultivation assays with the ascomycetous fungus Pseudoxylaria sp.X802 (Figs. 7a, S13, Tables S3 and  S4) 39 .Although isolated from three different geographic locations and habitats, all three strains exhibited comparable antifungal activity towards X802.We then performed a semi-targeted analysis of methanolic extracts of plate cultures of Amycolatopsis sp.PS_44_ISF1, A. saalfeldensis 40 , and Amycolatopsis sp.M39 using high-resolution ultra-high performance liquid chromatographyelectrospray ionization mass spectrometry (HR-UHPLC-ESI-MS).The acquired MS 2 data sets were analyzed using the Global Natural Products Social Molecular Networking (GNPS) platform 41 and results were visualized by Cytoscape (Figs. 7b, S14) 42 .
Comparative GNPS-based analysis revealed that the Amycolatopsis strains, although closely related and sharing highly similar gene clusters, showed a variety of distinct, and sometimes unidentified metabolite clusters.As expected, clusters containing molecular ion features of the known thiopeptide saalfelduracin A were detectable in A. saalfeldensis (Fig. 7d, TIC green) 40 , and Pseudoxylaria-derived cytochalasins 43 appeared as most dominant features in extracts of the co-culture interaction zones with A. saalfeldensis 40 (Fig. 7d, TIC orange).We were also able to identify shared metabolites, predominately common primary metabolites (membrane lipids, sugars), as well as one cluster related to macrolactams, with nodes (m/z = 515.276,m/ z = 499.281,Δm/z = 16) present in extracts from A. saalfeldensis and strain PS_44_ISF1, and nodes assigned to macrotermycins (m/z 489.258 (macrotermycin C, mteC), m/z = 473.266(macrotermycin A, mteA), Δm/z = 16, Fig. 7b) in extracts from strain M39.As the macrotermycin-like molecular ion features (m/ z = 515.276and 499.281) showed a mass difference of Δm/z = 26 to macrotermycin A and C, we hypothesized that the detected molecular ion features in A. saalfeldensis and Amycolatopsis sp.PS_44_ISF1 should contain an additional double bond (C 2 H 2 ) and thus likely match the predicted 22-membered macrolactam scaffolds of ciromicin A (V) and its precursor III (Fig. 6).We then pursued the cultivation only of Amycolatopsis sp.PS_44_ISF1 (120 ISP2 agar plates, 150 x 20 mm) as growth studies indicated sufficient macrolactam production for structural characterization (Fig. 7c, d).After seven days of growth, plates were extracted with methanol and compounds were purified by MS-and UV-guided reverse-phase HPLC (Supplementary Note 1, Fig. S15).While we were not able to isolate sufficient amounts of the light-sensitive metabolite III (m/z 499.281) for NMR-based structure analysis, we succeeded in the isolation of the macrolactam with molecular ion feature [M+H] + of 515.2766 (colorless solid, 0.6 mg).The observed strong λ max of 290 nm and the predicted sum formula C 28 H 38 N 2 O 7 matched with analytical data of the already reported macrolactam ciromicin A, carrying the predicted xylosamine sugar unit (m/z 132.066).Comparative 1D and 2D NMR and HRMS/MS fragmentation pattern analysis confirmed the relative structure as ciromicin A (Figs. 8a, S16-S24, Table S5) 6 .
Moreover, we also realized that the molecular ion feature m/z 473.266 ([M+H] + ) assigned to macrotermycin A in Amycolatopsis sp.M39 related to three different retention-times and distinct UV signals (Fig. 7b) indicating the presence of at least two macrotermycin congeners.Thus, we pursued the MS-guided purification of M39 culture extracts and were able to isolate all three derivatives, which were named macrotermycins E-G (Fig. 8B, Supplementary Note 2).Based on 1D and 2D NMR analyses, macrotermycins E and F (m/z 473.2652 [M+H] + ) exhibited the same planar structure as macrotermycin A 24 .Based on the observed ROESY correlation at H-15/H-18, we propose that macrotermycin E (2) and F (3) are C-18 stereoisomers of macrotermycins A (Fig. 8).Moreover, when comparing the 2D ROESY correlations of previously isolated macrotermycin A with those obtained from the herein isolated macrotermycins E (2) and F (3) (Figs.S25-S53, Tables S6-S11), we observed major inconsistencies in the description of the structural assignment of macrotermycin A (stereoconfiguration of C-7 originally depicted as R*) 24 .Based on the herein available comparative analysis, we propose now that the C-7 stereochemistry of macrotermycin A requires revision to 7S*, and that macrotermycins E and F are C-7 stereoisomer of macrotermycin A, thus exhibiting a 7R* stereoconfiguration.To support this assumption, we revisited the module organization of the PKS in the macrotermycin (mte) cluster and all ciromicin-related clusters (pac, asa, cir).Signature sequence alignment of all KR domains within modules 1-9 of all four clusters (module 10 lacked a KR domain in all four clusters) clearly showed that all domains share identical KR stereospecificities (Fig. S10) 44 .The KR of module 6 (KR6) was assigned as the only A1-type KR 24 , and correlated to a C-7-(S)-OH in case of the macrotermycin core structure, and to a C-9-(S)-OH in the ciromicin core structure 24,45 .In contrast, KR4 and KR7-9 were assigned as B-type KRs, which would result in an intermediate (R)(R)-OH configuration at C-2, C-4, C-10 of macrotermycin intermediates (C-2, C-4, C-6 and C-12 of ciromicin A intermediates) before dehydration to (trans) double bonds.In contrast, KR1-3 and KR5, could neither be assigned to an A-or B-type KR within all four clusters; however, their hydroxylated biosynthetic intermediates products are likely transformed to double bonds at position C-8, C-12, C-14, C-16 in macrotermycins (C-10, C-14, C-16, and C-18 in ciromicins) by the co-located dehydratase of the respective modules (Fig. S10).Here, it was noted that position C-8 in macrotermycin and position C-10 in ciromicin exhibit an identical double-bound stereochemistry (cis), whereas the configurations for all other double bond positions differed (ciromicin A: 14E, 16Z, 18E; macrotermycin A: 12Z, 14E, 16Z).We acknowledge at this stage that studies on the co-linearity between KR domain specificity and double bond geometry still remains debated due to similar numbers of exceptions to this theory as exemplified in the biosynthetic studies on the macrolactam verticilactam 46 , and consequently refrain from deducing the double stereochemistry based on sequence alignment only.The isolation of two additional macrotermycin stereoisomers (C-7 and C-18) indicated that at least two biosynthetic steps within the mtepathway are more promiscuous than originally anticipated: (1) the formation of the β-amino acid 3-Amp and/or its acceptance to the PKS, and (2) the specificity of the ketoreductase KR6 (MteP4).Both findings require future studies to fully elude their selectivity.
As the macrolactam scaffold is prone to undergo a light, heat, or acid-induced 2+4 cycloaddition reaction -most likely during work-up procedures -yielding either cycloaddition products of type I and after an acid or base-catalyzed 1,4-addition reaction tetracyclic ethers of type II, we also conclude at this stage that macrotermycin A and E should serve as cycloaddition precursor for the formation of macrotermycin B and G, respectively (Fig. 8c).
Heterologous expression of the asa BGC.We then aimed to verify the hypothesized asa biosynthetic pathway from A. saalfeldensis and enable its genetic manipulation by heterologous expression in a Streptomyces host.The entire macrolactam cluster region (105.6 kb) including the γ-butyrolactone-related genes and surrounding open reading frames (4 kb left and right of the core cluster) were obtained by in vitro CRISPR-mediated cleavage and transferred into the integrative pDualP vector (Terra Bioforge (Madison, USA)) resulting in the expression vector pAsa (Figs.9b, S54, Table S12).The vector was chosen as it contained two Streptomyces-specific inducible promoters flanking the inserted BGC.The first promotor Potr 47 upstream of the cluster, can be activated by oxytetracycline dihydrate (OXT), while PnitA 48, 49 downstream of the cluster, can be induced in the presence of ε-caprolactam (ε-CL).For heterologous expression of the gene cluster, three Streptomyces hosts were selected (S. lividans TK24 (1), S. albus J1074 (2), and S. coelicolor M1146 (3), Fig. 9a) and the integrative expression vector pAsa was introduced via triparental intergeneric conjugational transfer.Exconjugants were confirmed by colony PCR and Sanger sequencing (Fig. 9c, Table S13, and Figs.S55-S56).
To test if macrolactam production is inducible, S. albus::pAsa, S. lividans::pAsa and S. coelicolor::pAsa were cultivated on agar plates using four different growth conditions: (1) ISP2 medium + no induction (basal expression), (2) ISP2 + OXT (induction of promotor Potr), (3) ISP2 + ε-CL (induction of promotor PnitA) and (4) ISP2 + OXT + ε-CL (induction of both promotors).Streptomyces wild types (host strain without plasmid) served as control.Agar plates were extracted with EtOAc, and concentrated extracts were analyzed by HRMS/MS and comparative GNPS analysis, using MS/MS data of A. saalfeldensis and PS_44_ISF1 as reference (Fig. S57).Unexpectedly, we also noted that the presence of either one of the inducers lowered production titers in S. albus::pAsa compared to the basal induction conditions (Fig. 9e, Figs.S58-S60).We also tested different growth conditions (DNPM production medium, ISP2, mannitol-soy flour medium (MS) and vegetative medium (VM), agar and broth, Table S3), but without any notable improvement in yields and production titer (Fig. 9f).Semi-targeted metabolomic analysis uncovered instead that S. albus J1074 produced under inducing conditions a variety of intrinsic secondary metabolites, including antimycins, candicidins 50 , surugamides 51 , and desferrioxamines (Figs.S59-S60) 52 .While we were not able to detect ciromicin-related m/z features by targeted or untargeted measures, we found instead HRMS/MS features within the compound cluster that fitted to a proposed biosynthetic intermediate III (m/z 499.28, see Fig. 6) in S. albus::pAsa (Fig. 9d,  f).The formation of precursor III suggests that the cytochrome P450 enzyme AsaO1/PacO1 proposed to catalyze the oxidation at C-8 and/or C-19 is either dysfunctional when expressed in the host S. albus, or not responsible for both oxidation events 6 .Therefore, we cannot exclude that another enzyme located in a different locus of the Amycolatopsis genome might account for the second oxidation step, suggesting that the ciromicin precursor III does not exhibit a pyrrolidinol moiety (Fig. 6).

Conclusion
By application of macrolactam-specific query sequences, we uncovered a wide distribution of putative macrolactam producers within the phylum Actinobacteria and were able to differentiate general-specific trends in the abundance of macrolactam BGC types.Our analysis suggested that about 10% of all members of certain actinobacterial genera might harbor a macrolactamrelated BGC, with 3-Amp and 3-Aba-type derivatives being most abundant, whereas 3-Afa and β-Phe BGCs seem to be more exclusive for some bacterial genera.In-depth analysis of macrolactam BGCs encoded in Amycolatopsis spp.revealed that mutations within certain PKS regions are the major cause of the varying ring sizes of the produced macrolactam.Our comparative analysis also showed that macrolactam BGCs contain three main systems of regulation, including LuxR family regulators, sensor histidine kinase two-component systems and γ−butyrolactone regulatory systems.This suggests a complex regulation of macrolactam biosynthesis, and understanding these mechanisms and the environmental stressors that might activate transcription of macrolactam BGCs will help to discover their full potential.Based on our genomic and metabolomic analyses, we identified two cirlike gene cluster homologs in Amycolatopsis sp.PS_44_ISF1 (pac) and A. saalfeldensis (asa), respectively, and were able to verify the prediction by isolation of ciromicin A. Furthermore, we were able to pursue the heterologous expression of the asa BGC in S. albus J1074, which allows for future manipulation of the macrolactam pathway to deduce the biochemistry and promiscuity of single biosynthetic steps.In addition, metabolomic analysis led to the isolation of three to the best of our knowledge unreported macrotermycin derivatives from Amycolatopsis strain M39 and comparative NMR analyses, enabled us to determine their relative stereoconfiguration and revise the stereochemistry of macrotermycin A.

HR-MS.
High-resolution ultra-high performance liquid chromatography electrospray ionization mass spectrometry (HR-UHPLC-ESIMS) measurements were carried out on a Dionex Ultimate3000 system (Thermo Scientific) combined with a Q-Exactive Plus mass spectrometer (Thermo Scientific) equipped with an electrospray ion (ESI) source and a Luna Omega C18 column (100 × 2.1 mm, particle size 1.6 μm, pore diameter 100 Å).The column oven was set to 40 °C, scan range of MS was set to m/ z 200 to 2000 with a scan speed of 10,000 u/s and event time of 0.25 s under positive mode.DL temperature was set to 250 °C with an interface temperature of 350 °C and a heat block of 400 °C.The nebulizing gas flow was set to 1.5 L/min and dry gas flow to 15 L/min.A combination of data-dependent MS/MS analysis and Top10 experiments was applied, and measurements were performed in centroid mode with a resolving power of 17,500 at m/z 200, an isolation window of 1 m/z and stepped normalized collision energy of 20/30/40.For structure elucidation MS/MS spectra for 1 and its congeners were predicted using CFM-ID 4.0 53 and compared to the experimental MS/MS spectra.GNPS analysis.Tandem mass spectrometry molecular networks were created using the GNPS platform (http://gnps.ucsd.edu).Data were first converted to the.mzML format with MS-Convert 54 .The converted files were used to generate an MS/MS molecular network using the GNPS Data Analysis workflow version release 30.The precursor and fragment ion mass tolerance were set to 0.02 Da and to a product ion tolerance of 0.02 Da.Networks were generated using four minimum matched ion fragments, a minimum cluster size of 2 and a cosine score of 0.75-0.8,depending on the experiment.The remaining parameters were kept at default.The library spectra were filtered in the same manner as the input data.All matches kept between network spectra and library spectra were required to have a score above 0.7 and at least six matched peaks.After analysis, data were opened and visualized using Cytoscape 3.8.0software 42 .
Analytical and preparative HPLC.The high-performance liquid chromatography (HPLC) was carried out by using an Agilent 1290 UHPLC system (Agilent Technologies, Santa Clara, California, United States), which was outfitted with a 1290 Infinity binary pump.For the semi-preparative HPLC, analytical grade solvents were used by J.T. Baker (Philipsburg, NJ, USA) and Burdick & Jackson (Muskegon, MI, USA).
NMR. NMR spectra were collected using an NMR spectrometer outfitted with a Bruker CryoPlatform (DMSO-d 6 , 700 MHz and 900 MHz) at the Korea Basic Science Institute in Ochang, Korea.MestReNova ver.12.0.1 was used to process the data for the NMR spectra.
Detection of macrolactam BGCs in public genomes.To evaluate the distribution of macrolactam BGCs among bacterial families and to compare the relative abundance of the different macrolactam BGC types, homology searches were conducted using cblaster v1.3.11 26.Key biosynthetic genes with unique occurrence in macrolactam BGCs from four representative BGCs (vicenistatin, incednine, cremimycin, hitachimycin) were chosen as query sequences, such as 1) the VinN-type adenylation enzyme, which transfers an amino acid starter unit on the stand-alone VinL-type ACP, 2) the VinM-type adenylation enzyme protecting the free amino group by aminoacylation with L-alanine, and 3) the VinK-type acyltransferase responsible for the transfer of the dipeptidyl group to the loading-ACP of the first PKS enzyme in the assembly line 3 .To be able to distinguish between the different macrolactam BGC types, sequences of the enzymes responsible for the biosynthesis of the β-amino acid starter unit were included: (1) glutamate mutase (VinH, VinI) and decarboxylase (VinO/FlvO) 5,13 for BGCs containing 3-amino-2methylpropionate (3-Amp) and β−alanine starter unit (β-Ala), (2) glutamate-2,3-aminomutase (IdnL4) 9 and decarboxylase (IdnL3) for 3-aminobutyrate starter unit (3-Aba), (3) phenylalanine-2,3-aminomutase (HitA) for BGCs with β-phenylalanine starter unit (β-Phe), ( 4) thioesterase (CmiS1) and flavin adenine dinucleotide (FAD)-dependent oxidase (CmiS2) responsible for the biosynthesis of 3-amino fatty acid starter units 55 .In addition, one PKS protein sequence (IdnLP1) was added to each set of queries to enable the detection of PKS genes in proximity of the starter biosynthesis.However, it must be noted that due to the highly varying size and module composition of the PKS enzymes in macrolactam clusters, PKS homologs are not reliably detected (cut off pairwise identity 50%) Due to the size of macrolactam BGCs (~60-120 kb) analysis default parameters were adjusted: The maximum distance between any two hits in a cluster (−g, default: 20,000 bp) was set to 80,000 bp accounting for the possibility of long gaps between two hits, e. g. interrupted by long PKS genes.The minimum number of total hits in a cluster (-u) was set to N-2 (N = number of query sequences) to discard clusters which lack homologs to more than two query sequences.For β-Ala BGCs this parameter was set to N − 4 to detect clusters with the absence of VinH/I homologs.The parameters -ig and -md 70,000 were set to enable the detection of intermediate genes (−ig) between and adjacent to the homology hits in one cluster (maximum distance (-md): 70,000 bp).These parameters enable the visualization of surrounding genes using the plot_clusters argument to check for the presence of neighboring PKS genes which are also essential for macrolactam biosynthesis.After analysis, cluster hits were curated manually by firstly removing all duplicates within one BGC type.Cluster hits with unclear cluster architecture (e.g., on contig edge with no PKS genes in proximity) were re-evaluated manually using antiSMASHV6.0 56and removed from the analysis if necessary.Then, shared hits between two BGC types were detected to evaluate the specificity of the chosen query sequences for one BGC type and to detect duplicates.Duplicates were uploaded to antiSMASH V6.0 56 and assigned to the appropriate BGC type.Curated results were summarized and sorted by bacterial genera and families.
Whole-genome sequencing of Amycolatopsis sp.M39 DNA extraction.Cultures of Amycolatopsis sp.M39 (50 ml) were prepared in ISP2 broth and cultivated for 7 days at 30 °C and shaking at 150 rpm.Bacterial pellets were harvested, frozen in liquid nitrogen, and grounded to a fine powder.DNA was extracted using DNeasy Plant Mini Kit (Quiagen) according to manufacturer's instructions and subsequently precipitated using isopropanol.The precipitated DNA was washed with 95% ethanol, dried, and dissolved in water before subjecting it for sequencing.
Whole genome sequencing.Whole-genome sequencing was performed using a 150 bp paired-end shotgun Illumina sequencing at KIT, Germany.Additionally, Oxford Nanopore technology (Oxford Nanopore Technologies, Oxford, UK) was employed for long-read sequencing.Library preparation for ONT long-read sequencing was performed using the Ligation Sequencing (SQK-LSK109) and Native Barcoding Expansion 1-12 (EXP-NBD104) kits.The ONT protocol for native barcoding genomic DNA to multiplex 12 samples on one flow cells was used.A 48 h sequencing run was performed with the MinION Mk1B device and a 9.4 flow cell using the "super accuracy" basecalling in MinKNOW (v22.12.7).Basecalling and demultiplexing was automatically executed by the integrated basecaller GUPPY (v6.5.6).As a first step of genome assembly, read ends were trimmed manually using SNIKT (Slice Nucleotides Into Klassifiable Sequences v0.5.0) 57 removing the first 75 and last 60 bases.Afterwards, mild long-read polishing was applied with Filtlong (v0.2.1) removing reads below 1 kbp length 58 .Filtlong was used to remove 10% of low-quality length-filtered reads based on read quality 59 .Subsequently, the polished reads were assembled with Flye (v2.9.2) and rotated with rotated according to the Wick et al. perfect bacterial genome assembly tutorial prior to the second polishing step 60 .Lastly, the long-read genomes were polished using Medaka (-m r941_min_sup_g507, v1.8.0) 61 .
Co-cultivation studies.Co-cultivations of Pseudoxylaria sp.X802 with Amycolatopsis spp.were performed 40 .In short, a 50 µL droplet of a 7 day-old 20 mL A. saalfeldensis, Amycolatopsis sp.PS_44_ISF1 or Amycolatopsis sp.M39 pre-culture in ISP2 was placed at the center of a 150 × 20 mm PDA plate and incubated for 7 days at 28 °C.Afterwards four 1 cm 2 agar pieces of a 2week-old Pseudoxylaria sp.X802 culture were placed around the bacterium with a distance of 3 cm.Plates with only X802, A. saalfeldensis, PS_44_ISF1 or M39 served as axenic culture controls.Each co-cultivation and control set-up was prepared in five replicates.Cultures were incubated at room temperature for 3 weeks.Pictures were taken on day 1, 7, 14, and 20 of incubation.After 20 days samples (five agar plugs per sample) were taken from the bacterial colony, the fungal mycelium, and the inhibition zone of the co-cultures.Controls were sampled from axenic bacterial and fungal control plates.Samples (five agar plugs per sample) were transferred into a pre-weighed 250 mL Erlenmeyer flask and extracted twice with 100 mL of MeOH overnight at room temperature.The samples were passed through a filter and the solvent was concentrated under reduced pressure.The crude extract was dissolved in 20% MeOH and loaded on an activated SPE-C18 (100 mg) column, washed with 20% MeOH followed by stepwise elution with MeOH/H 2 O mixtures (50-100% MeOH).The elution fractions were combined and concentrated in vacuo.Samples were dissolved in MeOH to a concentration of 50 µg/mL and analyzed by HR-UPLC-MS/MS.The methanolic extracts of the Amycolatopsis strains in co-cultivation were compared using GNPS (cosine score: 0.75).To identify fungal metabolites in the co-cultivation extracts, methanolic extracts of X802 in cocultivation and axenic cultures were added.Lastly, PDA was used as control to remove metabolites originating from the medium.
Isolation of ciromicin A. For metabolite extraction from agar plates, 500 µL of a 7-day-old pre-cultures of A. saalfeldensis and strain PS_44_ISF1 were streaked on 120 ISP2 agar plates (150 × 20 mm).The cultures were sealed with parafilm and incubated at 30 °C for another 7 days.Plates were cut into small cubes (1 × 1 cm) and extracted with 6 L isopropanol in the dark overnight.Afterwards, the solvent was filtered off and evaporated in vacuo.The dried extract was then redissolved in 20% methanol and subjected to solid phase extraction (SPE).To remove media components, a 10 g C 18 column was activated with 100% methanol (MeOH) (2 column volumes (CV)) and equilibrated with 20% methanol.Afterwards the extract was loaded, washed with 20% methanol, and eluted with 50% and 100% MeOH (2 CV).The latter fractions were concentrated under reduced pressure, resuspended in MeOH, adsorbed on Celite and dried in vacuo.Prepacked C18 Sepak resin (2 g) was then loaded with the Celite-adsorbed extract.The extract was fractionated using an elution gradient of water and MeOH.Ciromicin A eluted in the 40% MeOH fraction, and this fraction was purified using semipreparative reversed-phase HPLC (ODS-A C18, 5 µm silica gel, 150 × 10.0 mm; YMC, Japan; flow rate of 3 mL/min; gradient solvent system: 0-5 min (13% aqueous acetonitrile), 5-20 min (13-20% aqueous acetonitrile over 15 min)) to obtain the pure ciromicin A which eluted at 16.9 min, yielding 0.6 mg from culture extracts of strain PS_44_ISF1 (See Supplementary Note 1).Isolation of macrotermycins.We performed a preparative scale fermentation of Amycolatopsis sp.M39 on solid ISP2 agar for 14 d at 30 °C (see Supplementary Note 1).Agar plates densely covered with mycelium were extracted using a mixture of MeOH and iPrOH.The crude extract containing macrotermycins was first purified using an activated pre-packed C18 Sep-Pak cartridge and SPE fractions eluted with 80% and 100% MeOH.Enriched extracts were purified by repetitive purification by semipreparative reverse-phase HPLC equipped with a phenyl-hexyl column and using variations of a gradient program with mixtures of water (A) and methanol (B); 0-5 min: 40% B; 5-30 min: from 40% to 100% B; 30-40 min: 100% B; 41-50 min: isocratic 40% B; total 50 min, flow rate: 10 mL/min).In total, we were able to isolate 0.8 mg of 2, 0.7 mg of 3 and 0.9 mg of 4 from 6 L of ISP2 agar (80 plates) (See Supplementary Notes 2 and 3).Heterologous expression of asa BGC from A. saalfeldensis Construction of the expression vector pAsa.For heterologous expression of the asa BGC from A. saalfeldensis an inducible dual-promotor expression vector harboring the complete asa BGC was constructed by Terra Bioworks (pAsa).For vector construction, isolated gDNA of A. saalfeldensis was cut with Cas9 using guide RNA sequences (Table S12).The Cas9 digestion was monitored by qPCR assays using primers designed for both the left and right cut sites of the cluster and was verified to have greater than 70% efficiency before moving forward with DNA assembly.DNA assembly of the genomic preparation was then performed to linearized pDualP vector containing overlap regions specific to the target fragment.The DNA assembly reaction was transformed to E. coli BacOpt2.0 from which we recovered colonies (21 transformants, 62% correct by colony PCR).Colonies were assayed via colony PCR using primers for both the left and right cloning junctions and confirmed by Sanger sequencing.Clones for the construct were restriction digested separately by EcoRI and BamHI and compared to a simulated digest to confirm the insertion of the whole BGC into the vector backbone.

Physical data. Ciromicin
Conjugational transfer of the expression vector to Streptomyces.For heterologous expression, three Streptomyces hosts were chosen: S. albus J1074, S. coelicolor M1146 and S. lividans TK24.The integrative expression vector pAsa was introduced into Streptomyces spp.via intergeneric conjugational transfer with minor modifications 62 .For a triparental conjugation, 10 mL E. coli BacOpt2.0::pAsa and the helper strain E. coli K12 HB101::pRK2013 in LB medium (supplemented with 50 µg/mL Apr for pAsa, 50 µg/mL Kan for pRK2013) were grown at 37 °C to an OD 600 of 0.4-0.5.Cultures were centrifuged at 6000 × g for 15 min, washed twice with ice-cold LB to remove residual antibiotics, and resuspended in fresh 1 mL LB without antibiotics.Streptomyces spore suspensions (50 µL, 2 × 10 8 spores, in 25% glycerol) were added to 500 µL of 2 × YT medium and heat shocked at 50 °C for 10 min.Equal amounts (v/v) of donor (E. coli mixture 1:1) and recipient cells (Streptomyces spores) were mixed, and the bacteria were pelleted by centrifugation.The medium was discarded, and the pellets were resuspended in a residual 100 µL of medium.The suspension was streaked on MS agar plates, supplemented with 10 mM MgCl 2 .After incubation for 16-20 h, the plates were overlaid with 1 mL of water containing 0.5 mg of nalidixic acid (NA) and 1.25 mg of apramycin, and incubation at 30 °C was continued for 5-7 days.Exconjugants were streaked on MS (with 50 µg/mL Apr and 25 µg/mL NA).For verification of vector insertion, a PCR using the primer pairs L-Asa and R-Asa was conducted (Table S13).PCR conditions were as follows: 98 °C/5 min, 30 cycles (98 °C/ 30 s, 61 °C/45 s, 72 °C/30 s), 72 °C/10 min.Reactions were performed in GC buffer supplemented with 5% DMSO.PCR products were then purified using a PCR gel extraction kit and sequenced via Sanger sequencing (Eurofins genomics).
Metabolic analysis of Streptomyces heterologous hosts.For analysis of macrolactam production in the heterologous hosts carrying the integrative and inducible expression vector pAsa.This vector is equipped with two Streptomyces-specific, inducible promoters flanking the inserted BGC.Potr 47 , upstream of the cluster, can be activated by oxytetracycline dihydrate (OXT) and PnitA 48,49 , downstream of the cluster, can be activated by ε -caprolactam (ε-CL).To test whether macrolactam production can be induced using one or both promotors, Streptomyces were tested in four different conditions: ISP2 + no inducer (basal expression), ISP2 + OXT (final concentration 2.5 µM), ISP2 + ε-CL (final concentration 0.1%) or ISP2 + both inducers simultaneously.First 20 ml pre-cultures of S albus::pAsa, S. coelicolor::pAsa, and S. lividans::pAsa in ISP2 (+ 50 µg/mL Apr, 25 µg/mL NA) were grown at 30 °C and 150 rpm for 7 days.Afterwards, 100 µL of the preculture were inoculated on ISP2 agar (plates 90 × 15 mm) with different inducer combinations and incubated at 30 °C for another 7 days in the dark.One plate of each Streptomyces strain and each treatment was cut into small cubes (1 × 1 cm) and extracted with 30 mL EtOAc overnight.The solvents were evaporated under reduced pressure and the dried samples were dissolved in MeOH to a concentration of 50 µg/mL and analyzed by HR-UPLC-MS/MS.To compare macrolactam production with producer strains MS/MS data was also used for GNPS analysis.
Media study to optimize macrolactam production.To optimize macrolactam production in S. albus::pAsa, production was tested on four different media (broth and agar): DNPM, ISP2, MS, VM.For agar cultivation, two agar plates of each medium (90 × 15 mm, 50 mL) were inoculated with 100 µL of a 7 day-old preculture of S. albus::pAsa in ISP2.For broth cultures, 50 ml of liquid medium were inoculated with 500 µL of the same preculture.After another 7 days of cultivation, agar plates were cut into small cubes (1 × 1 cm) and extracted with 50 mL MeOH overnight.Liquid cultures were filtered, and the medium was directly subjected to an SPE column (200 mg).On the next day, agar extracts were filtered, and the solvent was evaporated under reduced pressure.The raw extract was redissolved in 20% MeOH and subjected to an activated and equilibrated 1 g C 18 column.Afterwards the extract was washed with 20% MeOH and eluted with 50% and 100% methanol (2 CV).The latter fractions were combined and concentrated under reduced pressure.This procedure was the same for agar and liquid extracts.The dried samples were dissolved in MeOH to a concentration of 50 µg/mL and analyzed by HR-UPLC-MS/MS.Reporting summary.Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Fig. 1
Fig. 1 Planar chemical structures of β-amino acid starter units and macrolactams.Planar chemical structures of (a) ß-amino acid starter units; (b) icons representing the habitat from which the producing organism was isolated, and (c) chemical core structures and names of reported macrolactams, producer organism, and major biological activities.The stereochemical assignment of the macrolactam core structure was excluded to enhance clarity.
Fig.2The four phases of macrolactam biosynthesis exemplified by vicenistatin biosynthesis.In the first phase, enzyme-mediated transformations lead to the formation of the β-amino acid starter unit.The second step is common for all macrolactam BGCs and includes activation, protection and loading of the starter unit onto the first PKS.In phase 3, the polyketide chain is elongated by a PKS assembly line following deprotection and macrolactamization.Post-assembly modifications are introduced via accessory enzymes and spontaneous intramolecular cyclization may occur (phase 4).The stereochemical assignment of the macrolactam core structure was excluded to enhance clarity.

Fig. 3
Fig. 3 Organization and distribution of macrolactam and β-amino acid starter unit biosynthesis encoding biosynthetic gene clusters.a) A macrolactam-specific cblaster homology search (tblastn) was designed, which included dedicated enzymes involved in β-amino acid biosynthesis (I) and incorporation (II, light blue), and one PKS (IdnP1) to account for the presence of a type I PKS assembly line (gray).b) Abundance (absolute; relative) of macrolactam BGCs among bacterial families based on a cblaster analysis against the NCBI database.c) Classification of predicted macrolactam clusters by BGC type (according to starter unit) and comparison of their abundance (absolute; relative).Abbreviations: A domainadenylation domain, ACPacyl carrier protein, AT domainacyltransferase domain, GTglycosyltransferase, MTmethyltransferase, Oxcytochrome P450 monooxygenase.

Fig. 4
Fig.4Representative comparative cluster gene map of macrolactam BGCs encoding the 3-Amp starter unit biosynthesis in Amycolatopsis.Comparison of the pac, asa, cir, and revised mte BGC highlight the different positioning and module arrangement of genes encoding for the PKS and β-amino acid biosynthesis, as well as the varying locations of accessory and regulatory genes.

Fig. 5
Fig. 5 Revised proposal for macrotermycin biosynthesis in Amycolatopsis sp.M39.Proposed module organization, biosynthetic intermediates I-III and chemical structures of isolated macrotermycins (derivatives A, C, E and F in dashed brackets, for additional details, see Fig 8. (vide infra) and Fig.S12).The stereochemical assignment of the macrolactam core structure was partially excluded for clarity.

Fig. 6
Fig.6 Proposed biosynthetic pathway of ciromicin A based on the arrangement of the pac gene cluster.Depicted are the chemical structures of putative biosynthetic intermediates of the precursor biosynthesis (phase 1), intermediates in the PKS assembly line (phase 2) as deduced from the pac (Amycolatopsis sp.PS_44_ISF1) and asa (A.saalfeldensis) gene clusters, proposed structures of macrolactam intermediates I-IV (phase 4), the structurally characterized and isolated ciromicin A, and the structurally related niizalactams.

Fig. 7
Fig. 7 Representative co-cultivation assay of Amycolatopsis spp. with Pseudoxylaria sp.X802. a Representative co-cultivation plates showing the bacteria A. saalfeldensis, Amycolatopsis sp.M39 and Amycolatopsis sp.PS_44_ISF1 (B), competing fungus (F) and inhibition zone (IZ) 40 .b GNPS cluster showing the shared macrolactam cluster detected in A. saalfeldensis (green), M39 (blue), and PS_44_ISF1 (yellow).Edge labels depict mass differences between the metabolites and their annotations predicted by GNPS.HRMS chromatograms of methanolic extracts of different regions of the co-cultivation plates and axenic controls of Amycolatopsis sp.PS_44_ISF1 (c) and A. saalfeldensis (d).The first lane (TIC) shows the most abundant metabolites in the cocultivation.The following lanes show EICs of ciromicin A (cir, blue line) and its putative precursor (III, red line) in the culture area B (1), ZI (2), and F (4), as well as in the bacterial (3) and fungal (5) axenic controls and in the medium (PDA).The orange-and green-shaded peaks in the TIC of A. saalfeldensis cocultures represent the fungal cytochalasins and saalfelduracin A, respectively.*Metabolite of fungal origin.

Fig. 8
Fig. 8 Chemical structures of isolated ciromicin A (1) and macrotermycins.a Deduced chemical structure of ciromicin A based on major 2D NMR correlations.b Deduced chemical structure of macrotermycins E-G (2-4) and revised chemical structure of macrotermycin A based on comparative 2D NMR analyses.c Proposed conversion of macrotermycins of type A after exposure to light and/or heat to intermediate I (macrotermycins of type G) via 2+4 cycloaddition reaction, followed by an acid or base-catalyzed 1,4-addition to yield macrotermycins of type B (II).

Fig. 9
Fig. 9 Heterologous expression of the asa cluster in Streptomyces hosts.a Streptomyces hosts: S. lividans TK24 (1), S. albus J1074 (2) and S. coelicolor M1146 (3).b Vector map of the inducible expression vector pDualP harboring the asa cluster.For more details, see Fig. S54.c Verification of pAsa insertion in S. albus exconjugants 1-3 using primers L-Asa and R-Asa (wwild type control, vvector control).d GNPS cluster of macrolactams produced by Amycolatopsis spp.and heterologous strain S. albus::pAsa.e Extracted ion chromatograms of intermediate III (Fig. 6, EIC 499.2803 ± 5 ppm) in S. albus exconjugants carrying the asa BGC cultivated on ISP2 with different inducers.S. albus wildtype served as negative control and Amycolatopsis sp.PS_44_ISF1 as positive control.f Production of ciromicin precursor III by S. albus::pAsa in four different liquid and agar media.